2m 2m 2m 2m 2m 2m 2m
FORTE BIOSCIENC (FBRX)
NASDAQ
$16.23-$0.77 (-4.55%)
Price as of Jun 03, 2026 6:49 PM EDT- $390.5MMarket Cap
- 70.43%1-Year Change
- BiotechnologyIndustry
FORTE BIOSCIENC (FBRX)
$16.23-$0.77 (-4.55%)
FBRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.00 | ||
Change | -$1.17 (-6.46%) | ||
Open | $18.18 | ||
High | $18.59 | ||
Low | $16.67 | ||
Previous Close | $18.18 | ||
Volume | 354,630 | ||
30-Day Average Volume | 235,350 | ||
1-Week Change | -20.82% | ||
1-Month Change | -39.69% | ||
1-Year Change | 70.43% | ||
3-Year Change | -33.66% | ||
5-Year Change | -98.22% | ||
Fundamentals | |||
Shares Outstanding | 20.5M | ||
Total Assets | $67.2M | ||
Market Cap | $390.5M | ||
Enterprise Value | $332.3M | ||
Period: QTR TTM FY | |||
Revenue | -$7,000.00 | ||
Net Income | -$22.1M | ||
Free Cash Flow | -$18.8M | ||
EBIT | -$21.8M | ||
EBITDA | -$21.7M | ||
Net Working Capital | $41.5M | ||
EPS | -$1.24 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | -47,473 | ||
P/B | 9 | ||
P/E | -15 | ||
PEG | N/A | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/28/2024 | ||
Earnings & Revenue